Skip to content

Lobbying by MS Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Organization

MS Canada

Meetings this Parliament
31
With MPs
19
Since Nov 2021
147
Active registrations
1

Most recent reported meeting: Sep 29, 2026.

Who they meet

Since the current Parliament opened.

MPs

Institutions

  • House of Commons20
  • Prime Minister's Office (PMO)7
  • Senate of Canada6
  • Innovation, Science and Economic Development Canada (ISED)5
  • Canada Revenue Agency (CRA)4
  • Health Canada (HC)3
  • Finance Canada (FIN)2
  • Justice Canada (JC)1

Registrations in effect

In-house (organization) In effect since Aug 24, 2026 Receives government funding

Filed by Pamela Valentine, President & CEO

Lobbyists

  • Alanah Duffy · Manager, Government Relations
  • Benjamin Davis · Senior Vice-President, Mission
  • Danielle Mandell · Vice President People & Community
  • Jeff Mamer · Senior Director, Community
  • Jennie Young · VP, Research and Scientific Engagement
  • Julie Kelndorfer · Director, Government Relations and Advocacy
  • Julie Petrin · Director, Strategy & Impact
  • Mona Bates · Senior Director, Community
  • Pamela Valentine · President & CEO
  • Sarah MacDonald · AVP Programs
  • Treena Gracey · Specialist, Mission and People

Institutions they may lobby: Accessibility Standards Canada, Atlantic Canada Opportunities Agency (ACOA), Canada Employment Insurance Commission, Canada Post Corporation (CPC), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Canadian Human Rights Commission (CHRC), Canadian Institutes of Health Research (CIHR), Canadian Transportation Agency (CTA), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Office of the Commissioner of Lobbying (OCL), Office of the Federal Housing Advocate, Office of the Information Commissioner of Canada (OIC), Office of the Privacy Commissioner of Canada (OPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Rural Economic Development (Minister’s Office), Senate of Canada, Service Canada (ServCan), Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Women and Gender Equality (WAGE)

What they're lobbying on (17)
  • Postal service disruption and the significant hardships these disruptions cause for Canadians and on health charities
  • We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
  • Safe Long-Term Care Act with respect to persons affected by MS
  • National Housing Strategy with respect for persons with MS and other chronic conditions and disabilities
  • Measures and funding for the charitable sector generally
  • Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers
  • Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
  • Establishment of national strategy for neurological conditions, with respect to persons with MS and other neurological conditions.
  • Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities
  • Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
  • Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
  • CIHR as it relates to federal funding & long term investment in health research
  • Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
  • Canada Health Transfer - health system funding transfer and agreements intended for provinces/territories to support the delivery of healthcare services, including MS care
  • Canada Health Act and regulations, as it relates to long-term and home care
  • Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities
  • Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

Registration 935976-14937-87. Look it up in the official Registry

Reported meetings

Spreadsheet
  • Reported by Pamela Valentine · In-house (organization)

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Read more

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Karen Hall · Associate Assistant Deputy Minister (Analysis), Finance Canada (FIN)
    • Pierre Leblanc · Director General, Personal Income Tax, Finance Canada (FIN)
    • Ariane Brule · Director, Social Tax Policy, Finance Canada (FIN)
    • Sima Joshi-Koop · Senior Tax Policy Officer, Finance Canada (FIN)
    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities Read more

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Justine Frame · Policy Advisor, Health Canada (HC)
    • Fatoumata Bah · Policy advisor, Health Canada (HC)
    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
    • Fahim Khan · Senior Policy Advisor, Finance Canada (FIN)
    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    CIHR as it relates to federal funding & long term investment in health research

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    and 2 more
    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities Read more

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Victoria Perak · Senior Advisor (Policy and Operations) Office of the Secretary of State (Canada Revenue Agency and Financial Institutions), House of Commons
    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities Read more

    Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Canada Health Act and regulations, as it relates to long-term and home care

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Read more

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Marilou McPhedran · Senator, Senate of Canada
    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Tom Kmiec · Member of Parliament
    • Sean Fraser · Minister of Justice and Attorney General of Canada, Justice Canada (JC)
    • Mohamed-Iqbal Ravalia · Senator, Senate of Canada
    • Alyth Roos · Special Assistant Policy, Prime Minister's Office (PMO)
    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    and 24 more
    • Jim Bélanger · Member of Parliament
    • Leslie Church · Member of Parliament
    • Sandra Cobena · Member of Parliament
    • Jennifer McKelvie · Member of Parliament
    • Salma Zahid · Member of Parliament
    • Jeremy Patzer · Member of Parliament
    • Gord Johns · Member of Parliament
    • Mike Kelloway · Member of Parliament; Parliamentary Secretary to the Minister of Transport and Internal Trade
    • Dan Mazier · Member of Parliament
    • Michael Ma · Member of Parliament
    • Colin Reynolds · Member of Parliament
    • Jamie Schmale · Member of Parliament
    • Aslam Rana · Member of Parliament
    • Terry Duguid · Member of Parliament
    • Anna Gainey · Member of Parliament
    • Gurbux Saini · Member of Parliament
    • Gurbux Saini · Member of Parliament
    • Catherine Dong · Staff for Hedy Fry, House of Commons
    • Ethan Manderville · staff for Bruce Fanjoy, House of Commons
    • Claudia Gallant · Stakeholder Relations Advisor, House of Commons
    • Mary Coyle · Senator, Senate of Canada
    • Amen Ben Ahmouda · Policy advisor, House of Commons
    • Jason Smedvik · staff to MP Ben Carr, House of Commons
    • Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Read more

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    and 15 more
    • Fares Al Soud · Member of Parliament
    • Dane Lloyd · Member of Parliament
    • Terry Sheehan · Member of Parliament
    • Tom Osborne · Member of Parliament
    • Mike Lake · Member of Parliament
    • Taleeb Noormohamed · Member of Parliament
    • Robert Oliphant · Member of Parliament
    • Jeff Kibble · Member of Parliament
    • Corey Tochor · Member of Parliament
    • Kim Pate · Senator, Senate of Canada
    • Marika Barbieri-Antonoglou · staff for MP John Zerucelli, House of Commons
    • Clara Geddes · Sr. Policy Advisor - Min. Diab's office, House of Commons
    • Hillary Morgan · Dir of Parl. Affairs, Senate of Canada
    • Pat Duncan · Senator, Senate of Canada
    • Paulette Senior · Senator, Senate of Canada
    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    and 12 more
    Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Canada Health Act and regulations, as it relates to long-term and home care

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Tom Pitfield · Principal Secretary, Office of the Prime Minister, Prime Minister's Office (PMO)
    • Katherine Heus · Deputy Director of Policy, Prime Minister's Office (PMO)
    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities Read more

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers

    Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Safe Long-Term Care Act with respect to persons affected by MS

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Annie Koutrakis · Member of Parliament
    • Carlos Leitão · Member of Parliament
    • Karim Bardeesy · Member of Parliament
    • Mélanie Joly · Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
    and 11 more
    Employment Insurance sickness benefits, with respect to creation of flexible benefits for persons with MS and other episodic disabilities Read more

    Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities

    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).

    Home care, with respect to creation with provincial/ territorial governments programs relating to increased home care for persons with MS and other disabilities/ diseases and the support of caregivers

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Bill C-64, An Act Respecting Pharmacare with respect for persons with MS and other chronic conditions and disabilities

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Canada Health Act and regulations, as it relates to long-term and home care

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Shalene Curtis-Micallef · Deputy Minister of Health, Health Canada (HC)
    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Canada Health Act and regulations, as it relates to long-term and home care

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Wayne Long · Secretary of State, Canada Revenue Agency (CRA)
    • François-Philippe Champagne · Minister of Innovation, Sciences and Economic Development, Innovation, Science and Economic Development Canada (ISED)
    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS. Read more

    Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities

    Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities

    Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV). Read more

    Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty

    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Jaeda Schilke · West and North Regional Advisor to the Minister of Health, House of Commons
    • Justine Frame · Policy Lead, House of Commons
    Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities Read more

    Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.

    Official report

  • Reported by Pamela Valentine · In-house (organization)

    • Charu Kaushic · Scientific Director, CIHR Institute of Infection and Immunity (III), Canadian Institutes of Health Research (CIHR)
    • Patricia Conrod · Scientific Director, CIHR Institute of Neurosciences, Mental Health and Addiction (INMHA), Canadian Institutes of Health Research (CIHR)
    • Nina Cluny · Associate Director, CIHR-INMHA, Canadian Institutes of Health Research (CIHR)
    • Janice Charette · Strategic Associate, Strategic Partnerships and International Relations, Canadian Institutes of Health Research (CIHR)
    CIHR as it relates to federal funding & long term investment in health research

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.